RETREG1 and cancer: Studies have found that after knocking out FAM134B, the migration rate and invasive capacity of colon cancer cells greatly increase, which indicates that FAM134B could inhibit tumor cell migration in tissues and may even prevent cancer cells from forming new metastases [84].